Occam Industries raises £3.3m to scale gimbal production
This article covers Occam Industries, a Ukrainian hardware startup, raising £3.3m in a seed funding round to scale gimbal production. The funding will expand its manufacturing capacity for stabilisation hardware, supporting imaging, industrial and healthtech applications and affecting investors and regional supply chains.
Ukraine’s M‑Fly (Occam Industries) has raised £3.3m in a seed funding round to scale gimbal production, the company said. The amount equates to roughly €3.8m and the funding will be used to expand manufacturing capacity for its stabilisation hardware.
Why it matters
A mid‑single‑digit million seed round for a Ukrainian hardware business underlines continuing investor interest in European deep‑tech and hardware startups, even as founders face supply‑chain and geopolitical pressures. Gimbals — precision stabilisers used in cameras and robotic platforms — can sit at the intersection of consumer, industrial and healthtech applications, so improved production capacity could unlock new commercial pathways and partnerships across Europe.
Inside the product
Gimbals mechanically stabilise movement and are a core component in imaging rigs, inspection drones and robotic arms. For healthtech, that can translate into steadier imaging for diagnostics, better instrument control in surgical robotics, and more reliable telemedicine hardware. Scaling production for such parts usually requires investments in quality control, precision machining, and supply‑chain integration — areas that commonly bottleneck hardware startups moving from prototypes to volume manufacturing.
Who are the investors?
The announcement did not name lead or participating investors. The filing lists Occam Industries as the business name associated with the raise, but no further investor details or syndicate breakdown were provided in the release.
If you're researching potential backers in this space:
- Explore our list of healthtech venture capital firms in the UK
- Browse our directory of healthtech angel investors in the UK
Founder perspective
The press release did not include quotes from founders or disclose senior leadership. The publicly stated objective is to expand gimbal production capacity, which suggests the immediate priorities will be manufacturing scale‑up, supplier qualification and meeting regulatory or sector‑specific quality standards where relevant.
The bigger picture
This deal adds to a steady stream of early‑stage funding into European hardware and healthtech companies aiming to bring precision devices out of labs and into reliable production. For UK and EU investors and partners, backing such manufacturers supports regional supply‑chain resilience and could feed into clinical and industrial customers seeking locally sourced components. For Ukraine, continued investment into technology manufacturing sends a signal that capital can still flow to firms building tangible hardware capabilities in the region.
Click here for a full list of 7,589+ startup investors in the UK